Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Shalby Ltd. Share Price
Day's Range
Day's Range
Low
₹163.37
High
₹170.00
Price Summary
| Previous Close | ₹165.46 |
|---|---|
| Day's Range | ₹163.37 - ₹170.00 |
| Open | ₹168.60 |
| 52 Week Range | ₹125.82 - ₹274.70 |
| Volume | 55,742 |
| Market Cap | ₹0.00 |
| Previous Close | ₹167.35 |
|---|---|
| Day's Range | ₹163.90 - ₹168.70 |
| Open | ₹168.70 |
| 52 Week Range | ₹125.70 - ₹274.50 |
| Volume | 1,517 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 92.23 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 226.15 |
| TTM EPS (₹) | 0.75 |
| P/E Ratio | 342.20 |
| Book Value(₹) | 1.82 |
| PAT Margin (%) | 0.18 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 7.07 |
| Trade Value ( ₹ in Lacs) | 2.54 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 226.15 |
| TTM EPS (₹) | 0.75 |
| P/E Ratio | 342.20 |
| Book Value(₹) | 1.82 |
| PAT Margin (%) | 0.18 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 7.07 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 2206.4 | 8296.83 |
| Expenses | N/A | N/A |
| PBT | 357.7 | 1583.12 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 208.58 | 1038.45 |
About Shalby Ltd.
| Founded | 2004 |
|---|---|
| Managing Director | Vikram Shah |
| NSE Symbol | SHALBY |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,43,229.15 | 1,872.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,100.22 | 6,728.70 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,48,250.95 | 4,512.30 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,16,391.52 | 8,085.00 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,08,864.87 | 1,304.70 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,08,721.36 | 2,249.70 | 1,836.80 - 1,836.80 |
| Dr. Reddy's Laboratories Ltd. | 1,07,942.01 | 1,282.15 | 1,138.50 - 1,138.50 |
| Mankind Pharma Ltd. | 1,00,199.63 | 2,456.00 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 98,526.33 | 1,040.85 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 94,475.31 | 956.65 | 835.50 - 835.50 |
No Records Found
Latest News
Shalby informs about board meeting
Shalby informs about scrutinizers report
Shalby informs about updates
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shalby has informed that Krishna Shalby Hospital, Ahmedabad, has inaugurated its Oncology Department along with advanced Radiotherapy facilities. The introduction of these oncology and radiotherapy services will ensure that patients have access to comprehensive cancer treatment under one roof. With the launch of these advanced services, the hospital is now equipped to provide integrated cancer care. The department is supported by an experienced team of medical, radiation, and surgical oncologists, enabling patients to receive specialized diagnosis and treatment at a single location. Through advanced technology, expert medical teams, and a patient‐centric approach, we aim to ensure timely diagnosis and effective treatment for patients in and around Ahmedabad
Shalby informs about newspaper publication
Sai Life Sciences informs about earnings conference call
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Shalby Ltd. is ₹165.46 as of 2026-05-11.
The market capitalisation of Shalby Ltd. is ₹1,822.12 as of 2026-05-08.
The 1-year return of Shalby Ltd. is -3.14% as of 2026-05-11.
The P/E ratio of Shalby Ltd. is 342.20 as of 2026-05-11.
The 52-week high and low of Shalby Ltd. are ₹274.70 and ₹125.82, respectively, as of 2026-05-11.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
